BGNE Rating

Crunching data... Almost there!

BGNE Intrinsic Value

Crunching data... Almost there!

BGNE Share Price History

1W 2.0%
1M 23.3%
6M 40.9%
YTD 28.1%
1Y 39.9%
3Y (6.5%)
5Y 45.2%
10Y 700.5%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
$140.0$160.0$180.0$200.0$220.0$240.0Mar'24Apr'24May'24Jun'24Jul'24Aug'24Sep'24Oct'24Nov'24Dec'24Jan'25
Value Sense

BGNE Stock Metrics

Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

BGNE Stock Financials

BGNE Income Statement Metrics

Crunching data... Almost there!

BGNE Cash Flow Statement Metrics

Crunching data... Almost there!

BGNE Income Statement Overview

Crunching data... Almost there!

BGNE Balance Sheet Overview

Crunching data... Almost there!

BGNE Stock Ratios

Crunching data... Almost there!

BGNE Earnings Surprises

Crunching data... Almost there!

BGNE Dividends

BGNE Dividend Yield

Crunching data... Almost there!

BGNE Dividend Per Share

Crunching data... Almost there!

Competing with BGNE

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!

FAQ

What is BeiGene, Ltd. (BGNE) stock rating?

As of today, BeiGene, Ltd. has a stock rating of 5 (out of 10), which is considered Good.

is BeiGene, Ltd. (BGNE) a good stock to buy?

As of today, BeiGene, Ltd. has a Good stock rating, which is 1,137.7% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.